AKT1 and Coffin-Lowry syndrome: The molecular basis of CLS lies in loss-of-function mutations in the RSK2 gene (also known as RPS6KA3), which encodes a serine/threonine protein kinase crucial for chromatin design and cellular signaling pathways in humans [82].